Furthermore, we explore the interrelationship between BCAAs and FGF21 as critical biomarkers of metabolic health and aging (Choi et al. 2024; Luo et al. 2017), providing new insights into metabolic adaptations that may inform therapeutic strategies for obesity‐related disorders. This evidence concerns the gene FGF21 and obesity disorder.